. Author manuscript; available in PMC: 2015 Jun 2.

Published in final edited form as: Subst Use Misuse. 2014 Feb 6;49(7):783–792. doi: 10.3109/10826084.2014.880176

TABLE 3.

HSV-2 seroprevalence by HIV seroprevalence, sex, and race/ethnicity among NIDUs, New York City, 1995–1999 and 2005–2011

	Total Sample^** n+/Total N (%)	White n+/N (%)	African American n+/N (%)	Hispanic n+/N (%)
1995–1999
HIV-negative males^*	30/79 (39)	0/1 (0)	21/33 (64)	9/45 (20)
HIV-negative females^*	58/77 (75)	2/8 (25)	27/34 (79)	29/35 (83)
HIV-positive males	14/20 (70)	0	9/10 (90)	5/10 (50)
HIV-positive females	19/20 (95)	1/1 (100)	10/11 (90)	8/8 (100)
2005–2011
HIV-negative males^*	608/1238 (49)	21/72 (29)	476/845 (56)	111/321 (35)
HIV-negative females^*	276/332 (83)	13/25 (52)	189/219 (86)	74/88 (84)
HIV-positive males	156/209 (75)	4/5 (80)	119/154 (77)	33/50 (66)
HIV-positive females	89/91 (98)	1/1 (100)	71/72 (99)	17/18 (94)

Significant difference for race/ethnicity by Chi-square test.

^**

Females had significantly higher HSV-2 prevalence than males in all HIV serostatus and time period comparisons except among HIV seropositives in 1995–1999 where P = 0.09.